Shanghai Cell Therapy Group Co., Ltd.

ACTIVE

上海市（市辖区）, 上海市, Hong Kong, Chinawww.shcell.comHolding1,144 employeesEstablished: 2013-11-29

Part of shanghai baize biotechnology co., ltd.

Clinical Trials

4 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2013

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

66.7%

Early Phase 1

16.7%

Not Applicable

11.1%

Trial Status Distribution

Completed

5.6%

Not yet recruiting

22.2%

Recruiting

55.6%

Unknown

16.7%

Clinical Trials

Trials sponsored by this organization (18)

An Antibody-armored Dendritic Cell in Patients With Solid Tumors

Phase 1

Recruiting

interventional

Feb 20268 participants

An Exploratory Study of CD19/CD22/BCMA CAR-T Cells (BZE2204) in Subjects With Relapsed or Refractory Autoimmune Diseases

Phase 1

Recruiting

interventional

Sep 202520 participants

Exploratory Study of Super DC Cell Injection in Preventing Recurrence After Radical Surgery for Tumors

Phase 1

Recruiting

interventional

Jul 202512 participants

An Exploratory Study of Chenghuang Circadian Rhythm Regulator in Subjects With Sleep Disorders

Not Applicable

Completed

interventional

Jun 202515 participants

A Dose Escalating Study of CD19/CD22/BCMA CAR-T Therapy in Relapsed/ Refractory Multiple Myeloma

Phase 1

Recruiting

interventional

Dec 202412 participants

A Dose Escalating Study of CD19/CD22/BCMA CAR-T Therapy in Relapsed or Refractory B Cell Non-Hodgkin Lymphoma(NHL)

Early Phase 1

Recruiting

interventional

May 202420 participants

An Exploratory Study by Fast CAR T Cells

Phase 1

Recruiting

interventional

Mar 202420 participants

The Exploratory Study About the Effect of Using Double Filtration Plasmapheresis (DFPP) Removing Inflammatory Cytokines, Lipids and Toxic Metal Ions in Peripheral Blood in Adults

Not Applicable

Unknown

interventional

Mar 2024250 participants

Page 1 of 3

Approvals

No approval data available

News

No news articles found

Back to Organizations